AstraZeneca clot worries complicate bid to vaccinate the world

Reviews by U.K. and European Union regulators finding potential links to the unusual side effects are another blow for the shot, a cheaper and easier-to-deploy product that many nations are counting on in a bid to end the pandemic

from mint - News https://ift.tt/3cXT4QI
https://ift.tt/eA8V8J